$5.26
-0.13[-2.41%]
At close: Apr 26
$5.26
0[0.00%]
After Hours: 4:20PM EDT
Travere Therapeutics
(NASDAQ:TVTX)Travere Therapeutics Stock (NASDAQ:TVTX), Insider Trading Activity
Travere Therapeutics: Insider buying and selling updated today.
Insider Shares Owned
3.867M
Insider Percentage Owned
5.08%
Institutional Shares Held
42.612M
Institutional Percentage Held
56.0%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 12, 2024 | Christopher Cline | CHIEF FINANCIAL OFFICER | -54 | $6.74 | -$363.96 | SELL | -0.08% | 70.849K | Apr 11 | View |
| Feb 02, 2024 | Eric Dube | CHIEF EXECUTIVE OFFICER | 115.878K | $8.70 | -$166.44K | GRANT | 49.37% | 350.6K | Jan 31 - Feb 01 | View |
| Feb 02, 2024 | WILLIAM ROTE | SENIOR VICE PRESIDENT, R&D | 20.236K | $8.71 | -$41.50K | GRANT | 33.46% | 80.72K | Jan 31 - Feb 01 | View |
| Feb 02, 2024 | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | 10.68K | $8.53 | -$24.06K | GRANT | 25.84% | 52.017K | Jan 31 - Feb 01 | View |
| Feb 02, 2024 | Elizabeth E Reed | SVP, GC & CORPORATE SECRETARY | 20.236K | $8.71 | -$41.50K | GRANT | 36.11% | 76.27K | Jan 31 - Feb 01 | View |
| Feb 02, 2024 | Peter Heerma | CHIEF COMMERCIAL OFFICER | 20.805K | $8.53 | -$35.79K | GRANT | 26.44% | 99.503K | Jan 31 - Feb 01 | View |
| Feb 02, 2024 | Jula Inrig | CHIEF MEDICAL OFFICER | 22.826K | $8.53 | -$18.55K | GRANT | 64.76% | 58.074K | Jan 31 - Feb 01 | View |
| Feb 02, 2024 | Christopher Cline | CHIEF FINANCIAL OFFICER | 21.182K | $8.53 | -$32.57K | GRANT | 42.60% | 70.903K | Jan 31 - Feb 01 | View |
| Jan 25, 2024 | Elizabeth E Reed | SVP, GC & CORPORATE SECRETARY | -2.062K | $8.96 | -$18.48K | SELL | -3.55% | 56.034K | Jan 23 | View |
| Jan 25, 2024 | Eric Dube | CHIEF EXECUTIVE OFFICER | -7.873K | $8.96 | -$70.54K | SELL | -3.25% | 234.722K | Jan 23 | View |
| Jan 25, 2024 | Christopher Cline | CHIEF FINANCIAL OFFICER | -853 | $9.07 | -$7.74K | SELL | -1.69% | 49.721K | Jan 23 | View |
| Jan 25, 2024 | WILLIAM ROTE | SENIOR VICE PRESIDENT, R&D | -2.062K | $8.96 | -$18.48K | SELL | -3.30% | 60.484K | Jan 23 | View |
| Jan 25, 2024 | Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | -910 | $9.07 | -$8.25K | SELL | -2.15% | 41.337K | Jan 23 | View |
| Jan 25, 2024 | Peter Heerma | CHIEF COMMERCIAL OFFICER | -1.559K | $9.07 | -$14.14K | SELL | -1.94% | 78.698K | Jan 23 | View |
| Jan 05, 2024 | Jula Inrig | CHIEF MEDICAL OFFICER | -2.509K | $9.43 | -$23.65K | SELL | -6.65% | 35.248K | Jan 03 - Jan 04 | View |
| Oct 04, 2023 | Peter Heerma | CHIEF COMMERCIAL OFFICER | -3.091K | $8.25 | -$25.50K | SELL | -3.71% | 80.257K | Oct 03 | View |
| Sep 05, 2023 | Christopher Cline | CHIEF FINANCIAL OFFICER | -457 | $14.71 | -$6.72K | SELL | -0.90% | 50.574K | Sep 05 | View |
| Sep 05, 2023 | WILLIAM ROTE | SENIOR VICE PRESIDENT, R&D | 1.485K | $14.71 | -$26.70K | GRANT | 2.49% | 61.173K | Aug 31 - Sep 05 | View |
| Sep 05, 2023 | Elizabeth E Reed | SVP, GC & CORPORATE SECRETARY | 1.485K | $14.71 | -$26.70K | GRANT | 2.62% | 58.096K | Aug 31 - Sep 05 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
TVTX Insider Trading News
No news found